794
Participants
Start Date
November 1, 2025
Primary Completion Date
March 1, 2028
Study Completion Date
May 31, 2028
TNK
a dose of 0.25 mg/kg (max 25 mg) administered as a bolus
Standard medical treatment
antiplatelet drugs, anticoagulation or combinations of these treatment modality according to national and institutional guidelines.
The First Affiliated Hospital of University of Science and Technology of China, Hefei
The First Affiliated Hospital of University of Science and Technology of China
OTHER